Skip to main content

Valeria Tubita

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Valeria Tubita

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Búsqueda de firmas proteómicas y dianas terapéuticas en el cáncer de ovario seroso de alto grado avanzado resistente a platino

IP: Antonio Gil Moreno
Collaborators: Vicente Bebia Conesa, Francesc Xavier Serra Marin, Marta Rebull Santamaria, Martina Angeles Fite, Ana Luzarraga Aznar, Melissa Bradbury Lobato, Beatriz Villafranca Magdalena, Melek Denizli , Lourdes Elena Salazar Huayna, Búsqueda de firmas proteómicas y dianas terapéuticas en el cáncer de ovario seroso de alto grado avanzado resistente a platino, Valeria Tubita
Funding agency: Instituto de Salud Carlos III
Funding: 196250
Reference: PI24/01509
Duration: 01/01/2025 - 31/12/2027

Terapia Combinada de SYD985 y Niraparib: Un Nuevo Horizonte en el Tratamiento Personalizado del Cáncer de Endometrio HER2/neu Positivo

IP: Valeria Tubita
Collaborators: -
Funding agency: Fundació Santiago Dexeus Font
Funding: 6000
Reference: DEXEUS/PROJECTE/TUBITA/2024
Duration: 30/12/2024 - 30/12/2026

Cytomark - Desarrollo de un test diagnóstico personalizado y no invasivo de cáncer de endometrio en el fluido cervical

IP: Eva Colas Ortega
Collaborators: Irene De la Calle Fuentes, Antonio Gil Moreno, Carina Masferrer Ferragutcasas, Raquel Delgado Gil, Valeria Tubita
Funding agency: Asociación Española Contra el Cáncer
Funding: 188000
Reference: PERME212443COLA
Duration: 01/01/2022 - 31/01/2026

Related news

The study evaluated the results of combining SYD985, a HER2 antibody conjugated to a potent cytotoxic drug, and niraparib, an inhibitor of DNA damage repair.

Researchers from the centre took part in international debates on AI in healthcare, spin-offs emerging from research were presented, and several initiatives linked to VHIR received recognition in the field of entrepreneurship.

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

Related professionals

Herrera Rey, Lara

Herrera Rey, Lara

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Alberich Jordà, Manel

Alberich Jordà, Manel

Research technician
Neuroradiology
Read more
Navas Moya, Elisabeth

Navas Moya, Elisabeth

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Ustrell Garrido, Cristina

Ustrell Garrido, Cristina

Research technician
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.